According to Sientra's latest financial reports the company has a price-to-book ratio of -0.0649.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | -0.2276 | -99.55% |
2022-12-31 | -50.1 | -1059.66% |
2021-12-31 | 5.22 | -101.48% |
2020-12-31 | -352 | -6614.55% |
2019-12-31 | 5.41 | -0.59% |
2018-12-31 | 5.44 | -44.89% |
2017-12-31 | 9.87 | 421.06% |
2016-12-31 | 1.89 | 111.43% |
2015-12-31 | 0.8961 | -65.77% |
2014-12-31 | 2.62 | |
2013-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Edwards Lifesciences EW | 7.63 | -11,848.63% | ๐บ๐ธ USA |
iRadimed IRMD | 7.76 | -12,056.47% | ๐บ๐ธ USA |
Cardiovascular Systems CSII | 3.53 | -5,529.77% | ๐บ๐ธ USA |
West Pharmaceutical WST | 10.1 | -15,597.62% | ๐บ๐ธ USA |